Bulk Manufacturer of Controlled Substances Application: Absolute Standards, Inc., 48868 [2018-21075]

Download as PDF 48868 Federal Register / Vol. 83, No. 188 / Thursday, September 27, 2018 / Notices issuance of the proposed registration on or before November 26, 2018. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (‘‘Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.33(a), this is notice that on July 10, 2018, Nanosyn, Inc., 3331–B Industrial Drive, Santa Rosa, California 95403– 2062 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances: SUPPLEMENTARY INFORMATION: Controlled substance Drug code Oxymorphone ....... Fentanyl ................ 9652 9801 or objections to the issuance of the proposed registration on or before November 26, 2018. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW 8701 Morrissette Drive, Springfield, Virginia 22152. The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (‘‘Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.33(a), this is notice that on August 27, 2018, Absolute Standards, Inc., 44 Rossotto Drive, Hamden, CT 06514 applied to be registered as a bulk manufacturer for the basic classes of controlled substances: SUPPLEMENTARY INFORMATION: Schedule II II Controlled substance Drug code Pentobarbital ........ The company is a contract manufacturer. At the request of the company’s customers, it manufactures derivatives of controlled substance in bulk form. Dated: September 19, 2018. John J. Martin, Assistant Administrator. 2270 Schedule II The company plans to bulk manufacture the listed controlled substance for distribution to customers. Dated: September 21, 2018. John J. Martin, Assistant Administrator. [FR Doc. 2018–21075 Filed 9–26–18; 8:45 am] BILLING CODE 4410–09–P [FR Doc. 2018–21074 Filed 9–26–18; 8:45 am] BILLING CODE 4410–09–P daltland on DSKBBV9HB2PROD with NOTICES DEPARTMENT OF JUSTICE DEPARTMENT OF JUSTICE Federal Bureau of Investigation Drug Enforcement Administration [OMB Number: 1110–0068] [Docket No. DEA–392] Agency Information Collection Activities; Proposed eCollection eComments Requested; Revision of a Currently Approved Collection: Records Modification Form (FD–1115) Bulk Manufacturer of Controlled Substances Application: Absolute Standards, Inc. ACTION: Notice of application. Registered bulk manufacturers of the affected basic class, and applicants therefore, may file written comments on DATES: VerDate Sep<11>2014 17:20 Sep 26, 2018 Jkt 244001 Criminal Justice Information Services Division, Federal Bureau of Investigation, Department of Justice. ACTION: 60-Day notice. AGENCY: PO 00000 Frm 00076 Fmt 4703 Sfmt 4703 The Department of Justice (DOJ), Federal Bureau of Investigation (FBI), Criminal Justice Information Services (CJIS) Division, will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and affected agencies. DATES: Comments are encouraged and will be accepted for 60 days until November 26, 2018. FOR FURTHER INFORMATION CONTACT: If you have additional comments especially on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact Gerry Lynn Brovey, Supervisory Information Liaison Specialist, FBI, CJIS, Resources Management Section, Administrative Unit, Module C–2, 1000 Custer Hollow Road, Clarksburg, West Virginia 26306 (facsimile: 304–625– 5093) or email glbrovey@fbi.gov. Written comments and/or suggestions can also be sent to the Office of Management and Budget, Office of Information and Regulatory Affairs, Attention Department of Justice Desk Officer, Washington, DC 20503. Additionally, comments may be submitted via email to OIRA_submission@omb.eop.gov. SUPPLEMENTARY INFORMATION: This process is conducted in accordance with 5 CFR 1320.10. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; —Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; —Evaluate whether and if so how the quality, utility, and clarity of the information to be collected can be enhanced; and —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms SUMMARY: E:\FR\FM\27SEN1.SGM 27SEN1

Agencies

[Federal Register Volume 83, Number 188 (Thursday, September 27, 2018)]
[Notices]
[Page 48868]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-21075]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Bulk Manufacturer of Controlled Substances Application: Absolute 
Standards, Inc.

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic class, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration on or before November 26, 2018.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW 8701 
Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: The Attorney General has delegated his 
authority under the Controlled Substances Act to the Administrator of 
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority 
to exercise all necessary functions with respect to the promulgation 
and implementation of 21 CFR part 1301, incident to the registration of 
manufacturers, distributors, dispensers, importers, and exporters of 
controlled substances (other than final orders in connection with 
suspension, denial, or revocation of registration) has been redelegated 
to the Assistant Administrator of the DEA Diversion Control Division 
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, 
appendix to subpart R.
    In accordance with 21 CFR 1301.33(a), this is notice that on August 
27, 2018, Absolute Standards, Inc., 44 Rossotto Drive, Hamden, CT 06514 
applied to be registered as a bulk manufacturer for the basic classes 
of controlled substances:

------------------------------------------------------------------------
         Controlled substance           Drug code         Schedule
------------------------------------------------------------------------
Pentobarbital........................         2270  II
------------------------------------------------------------------------

    The company plans to bulk manufacture the listed controlled 
substance for distribution to customers.

    Dated: September 21, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018-21075 Filed 9-26-18; 8:45 am]
 BILLING CODE 4410-09-P